Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Complex Regional Pain Syndrome
100%
Tumor Necrosis Factor-α
100%
Adalimumab
100%
Intention-to-treat
50%
Per-protocol Analysis
33%
Non-responders
16%
Pain Intensity
16%
McGill Pain Questionnaire
16%
Visual Analog Scale
16%
Mechanical Pain Threshold
16%
SF-36 Questionnaire
16%
Thermal Threshold
16%
Beck Depression inventory-II (BDI-II)
16%
Treatment Goals
16%
Patient Response
16%
Mechanical Threshold
16%
Von Frey Hair
16%
Partial Responder
16%
Per-protocol
16%
Humira
16%
Subcutaneous Injection
16%
Nursing and Health Professions
Tumor Necrosis Factor
100%
Adalimumab
100%
Complex Regional Pain Syndrome Type I
100%
Intention to Treat Analysis
60%
Complex Regional Pain Syndrome
40%
Visual Analog Scale
20%
Pain Intensity
20%
Pain Threshold
20%
Short Form 36
20%
McGill Pain Questionnaire
20%
Physical Disease by Body Function
20%
Beck Depression Inventory
20%
Subcutaneous Injection
20%
Pathogenesis
20%
Medicine and Dentistry
Complex Regional Pain Syndrome Type I
100%
Tumor Necrosis Factor
100%
Adalimumab
100%
Intention-to-Treat Analysis
60%
Complex Regional Pain Syndrome
40%
Short Form 36
20%
McGill Pain Questionnaire
20%
Visual Analog Scale
20%
Beck Depression Inventory
20%
Pain Threshold
20%
Physical Disease by Body Function
20%
Von Frey Hair
20%
Subcutaneous Injection
20%
Pathogenesis
20%
Neuroscience
Tumor Necrosis Factor Alpha
100%
Adalimumab
100%
Reflex Sympathetic Dystrophy
100%
Complex Regional Pain Syndrome
40%
Pain Threshold
20%
Beck Depression Inventory
20%
Immunology and Microbiology
Tumor Necrosis Factor Alpha
100%
Adalimumab
100%
Pain Threshold
20%